Inventor
MORIN PAUL E
US21 patents
⚠️ This page may combine multiple inventors who share the name “MORIN PAUL E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
20 patentsUS9434778B2Sep 6, 2016
Modified FGF-21 polypeptides comprising an internal deletion and uses thereof
BRISTOL MYERS SQUIBB CO31 citations97
US10406251B2Sep 10, 2019
PD-L1 binding polypeptides for imaging
BRISTOL MYERS SQUIBB CO15 citations92
US10189883B2Jan 29, 2019
Therapeutic uses of modified FGF-21 polypeptides
BRISTOL MYERS SQUIBB CO12 citations92
US9631004B2Apr 25, 2017
Modified FGF-21 polypeptides comprising an internal deletion and uses thereof
BRISTOL MYERS SQUIBB CO12 citations92
US9540424B2Jan 10, 2017
Serum albumin binding molecules
BRISTOL MYERS SQUIBB CO27 citations92
US10221438B2Mar 5, 2019
Serum albumin binding molecules
BRISTOL MYERS SQUIBB CO12 citations91
US11248031B2Feb 15, 2022
Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides
BRISTOL MYERS SQUIBB CO4 citations83
US10934572B2Mar 2, 2021
Serum albumin binding molecules
BRISTOL MYERS SQUIBB CO4 citations83
US10377806B2Aug 13, 2019
Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereof
BRISTOL MYERS SQUIBB CO6 citations83
US10266578B2Apr 23, 2019
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
BRISTOL MYERS SQUIBB CO9 citations82
US11344639B2May 31, 2022
PET imaging with PD-L1 binding polypeptides
BRISTOL MYERS SQUIBB CO4 citations71
US11173219B2Nov 16, 2021
PD-L1 binding polypeptides for imaging
BRISTOL MYERS SQUIBB CO4 citations71
US12247058B2Mar 11, 2025
Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereof
BRISTOL MYERS SQUIBB CO0 citations62
US12097242B2Sep 24, 2024
Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides
BRISTOL MYERS SQUIBB CO0 citations61
US12097241B2Sep 24, 2024
Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides
BRISTOL MYERS SQUIBB CO0 citations61
US11623965B2Apr 11, 2023
Prodruggable antibodies, prodrugs thereof, and methods of use and making
BRISTOL MYERS SQUIBB CO1 citations61
US11364281B2Jun 21, 2022
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof
BRISTOL MYERS SQUIBB CO0 citations61
US11185570B2Nov 30, 2021
Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides
BRISTOL MYERS SQUIBB CO0 citations61
US12194110B2Jan 14, 2025
PD-L1 binding polypeptides for imaging
BRISTOL MYERS SQUIBB CO0 citations60
US11623013B2Apr 11, 2023
Methods and compositions for deuterated biologics
BRISTOL MYERS SQUIBB CO0 citations57